TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study.
Neth Heart J
; 28(6): 312-319, 2020 Jun.
Article
em En
| MEDLINE
| ID: mdl-32162204
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article